SCHEMBL7055751

SCHEMBL7055751

O=C(Cl)/C=C/c1ccc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
MAPT P10636 7/20 0.52
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
HPGD P15428 5/20 0.52
PKM P14618 3/20 0.52
PRMT5 O14744 1/20 0.52
WDR77 Q9BQA1 1/20 0.52
NPC1 O15118 5/20 0.51
LMNA P02545 4/20 0.51
RAB9A P51151 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
TP53 P04637 1/20 0.51
KDM4E B2RXH2 5/20 0.49
HTT P42858 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
RECQL P46063 1/20 0.49
POLB P06746 1/20 0.48
MITF O75030 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6545574 1.00 ALDH1A1 (0.52) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL3500178 0.87 ALDH1A1 (0.55) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL3500182 0.87 ALDH1A1 (0.55) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL7054665 0.86 ALDH1A1 (0.51) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL6545936 0.86 ALDH1A1 (0.51) ALDH1A1MAPTMEN1KMT2AHPGD
Hydrochloric Acid SCHEMBL7055755 0.86 ALDH1A1 (0.54) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL7047336 0.81 MAPT (0.62) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL6546937 0.81 MAPT (0.62) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL2554418 0.77 KMT2A (0.50) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL2554420 0.77 KMT2A (0.50) ALDH1A1MAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036532-A1 Use of 2-phenylene diamine derivatives for the treatment of infections JOMAA PHARMAKA GMBH (DE) 2003-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036532-A1 Use of 2-phenylene diamine derivatives for the treatment of infections HRH2, ASPH, NQO2 ALDH1A1 1419/4885MAPT 4832/4885MEN1 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.